Updates in recurrent/metastatic nasopharyngeal carcinoma: The role of immune checkpoint inhibitors 

🔍 In this interview, Prof. Barbara Burtness answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma.
👉 Watch the interview here: touchoncologyi...
Or
Register now to stay informed: touchoncology....
This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME.
#Oncology #NasopharyngealCarcinoma #ImmuneCheckpointInhibitors #CancerTreatment #MedicalAdvances